EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mind the Curve: Dose–Response Fitting Biases the Synergy Scores across Software Used for Chemotherapy Combination Studies

Olga Fuentealba-Manosalva, Matías Mansilla, Neudo Buelvas, Antonia Martin-Martin, Cristian G Torres iD, Rodrigo A López-Muñoz iD

International Journal of Molecular Sciences · 03.06.2023 · 24 (11) · 9705

DOI: 10.3390/ijms24119705 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.06.2023. Verfasst von Olga Fuentealba-Manosalva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Farmacología y Morfofisiología, Facultad de Ciencias Veterinarias, Universidad Austral de Chile, Valdivia 5110566, Chile. Hauptthemen laut MEDLINE: Antineoplastic Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Investigación y Desarrollo, National Agency, Development of Chile (ANID-Chile).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug combinations are increasingly studied in the field of anticancer agents. Mathematical models, such as Loewe, Bliss, and HSA, are used to interpret drug combinations, while informatics tools help cancer researchers identify the most effective combinations. However, the different algorithms each software uses lead to results that do not always correlate. This study compared the performance of Combenefit (Ver. 2.021) and SynergyFinder (Ver. 3.6) in analyzing drug synergy by studying combinations involving non-steroidal analgesics (celecoxib and indomethacin) and antitumor drugs (carboplatin, gemcitabine, and vinorelbine) on two canine mammary tumor cell lines. The drugs were characterized, their optimal concentration–response ranges were determined, and nine concentrations of each drug were used to make combination matrices. Viability data were analyzed under the HSA, Loewe, and Bliss models. Celecoxib-based combinations showed the most consistent synergistic effect among software and reference models. Combination heatmaps revealed that Combenefit gave stronger synergy signals, while SynergyFinder produced better concentration–response fitting. When the average values of the combination matrices were compared, some combinations shifted from synergistic to antagonistic due to differences in the curve fitting. We also used a simulated dataset to normalize each software’s synergy scores, finding that Combenefit tends to increase the distance between synergistic and antagonistic combinations. We conclude that concentration–response data fitting biases the direction of the combination (synergistic or antagonistic). In contrast, the scoring from each software increases the differences among synergistic or antagonistic combinations in Combenefit when compared to SynergyFinder. We strongly recommend using multiple reference models and reporting complete data analysis for synergy claiming in combination studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsAnimalsDogsCelecoxibDrug Therapy, CombinationSoftwareDrug CombinationsDrug SynergismAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

chemotherapydrug combinationssoftwaresynergy

Substanzen

CelecoxibAntineoplastic AgentsDrug Combinations

Autor:innen und Institutionen

  • Instituto de Farmacología y Morfofisiología, Facultad de Ciencias Veterinarias, Universidad Austral de Chile, Valdivia 5110566, Chile.
  • Departamento de Ciencias Clínicas, Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile, Santiago 8820808, Chile.
  • Laboratorio Centralizado de Investigación Veterinaria (LaCIV), Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile, Santiago 8820808, Chile.

ORCID-Profile: Cristian G Torres, Rodrigo A López-Muñoz

Förderung

  • Agencia Nacional de Investigación y Desarrollo
  • National Agency
  • Development of Chile (ANID-Chile)

Zitieren

APA

Fuentealba-Manosalva, O., Mansilla, M., Buelvas, N., Martin-Martin, A., Torres, C. G., & López-Muñoz, R. A. (2023). Mind the Curve: Dose–Response Fitting Biases the Synergy Scores across Software Used for Chemotherapy Combination Studies. International Journal of Molecular Sciences, 24(11), 9705. https://doi.org/10.3390/ijms24119705

Vancouver

Fuentealba-Manosalva O, Mansilla M, Buelvas N, Martin-Martin A, Torres CG, López-Muñoz RA. Mind the Curve: Dose–Response Fitting Biases the Synergy Scores across Software Used for Chemotherapy Combination Studies. International Journal of Molecular Sciences. 2023;24(11):9705. doi:10.3390/ijms24119705

BibTeX
@article{FuentealbaManosalva2023,
  author = {Fuentealba-Manosalva, Olga and Mansilla, Matías and Buelvas, Neudo and Martin-Martin, Antonia and Torres, Cristian G and López-Muñoz, Rodrigo A},
  title = {Mind the Curve: Dose–Response Fitting Biases the Synergy Scores across Software Used for Chemotherapy Combination Studies},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {11},
  pages = {9705},
  doi = {10.3390/ijms24119705}
}
Kostenlos starten →